Genzyme's IPO

Genzyme raised a round of funding on June 13, 1986. Investors include Public.

Genzyme, a biotechnology company, engages in the discovery and development of products and services primarily in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases, and en…

Articles about Genzyme's IPO: